Category: Finance
-
Pharma Mergers Jump 20 Percent in 2010 [UPDATED]
Update: 12 January 2011. Life Science Analytics, the source of the statistics quoted in this entry, notes that the data refer to partnership deals, NOT mergers as the entry implies. The company asked that we post the following statement … Please note the reference to top deal makers in this article reflects their participation in…
-
Company Leads Consortium to Crystallize Parkinson’s Enzyme
Emerald BioStructures, a structural biology services company in Bainbridge Island, Washington, received a grant to lead a consortium to crystallize and solve the structure of the enzyme believed to be a key molecular mechanism behind Parkinson’s disease. The project, funded by the Michael J. Fox Foundation for Parkinson’s Research, includes researchers from the Helmholtz Association…
-
More International Collaboration Found in Nanotech Research
Investigators at Georgia Institute of Technology in Atlanta and Florida International University (FIU) in Miami reveal how research in nanotechnology has increasingly become a multi-national enterprise, despite having some 60 countries now funding nanotech initiatives within their borders. Phillip Shapira of Georgia Tech and Jue Wang of FIU found nearly a quarter of all published…
-
Industry Funding University Citrus Disease Research
Coca-Cola and Cutrale Citrus Juices said today at that they have each pledged $1.5 million to the University of Florida (UF) in Gainesville for research into citrus fruit diseases. The Citrus Research and Development Foundation (CRDF), a direct support organization of UF, will manage the funding from the two companies and the research program. The…
-
Merck To Acquire Biotech for Diabetes Treatment Technology
Merck & Co. Inc., a global pharmaceutical manufacturer, says it will acquire SmartCells Inc., a biotechnology company in Beverly, Massachusetts developing a glucose responsive insulin formulation for the treatment of diabetes. The SmartCells process was first developed at Massachusetts Institute of Technology by its president, Todd Zion. SmartCells says its technology makes it possible to…
-
Grant Boosts Research Commercialization Group
The Maryland Proof of Concept Alliance — a consortium of Maryland university research institutions and the U.S. Army Research Laboratory — has received a $5.1 million federal grant to support its work moving research findings from the lab to the marketplace. The Alliance helps researchers through the often tricky and (to the researchers) unfamiliar process…
-
Arthritis Drug Protects Against Non-Melanoma Skin Cancer
A widely used arthritis drug reduces the incidence of non-melanoma skin cancers according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib, approved for the treatment of osteoarthritis, rheumatoid arthritis, and acute pain in adults, led to a 62 percent reduction in non-melanoma skin cancers, which…
-
R&D Collaboration to Discover Drugs for River Blindness
Anacor Pharmaceuticals in Palo Alto California, the University of California San Francisco’s Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center established a research and development collaboration to discover new therapies to treat river blindness (onchocerciasis). River blindness is a parasitic disease and the second leading cause of…
-
Clinical Data Reported on Parkinson’s Biomarker Candidates
KineMed Inc., a drug discovery company in Emeryville, California says it recently presented data on a new use of cerebrospinal fluid biomarkers for the monitoring of disease progression and therapeutic interventions in Parkinson’s disease. The company reported the findings at a grant review meeting of the Michael J. Fox Foundation on 1 November 2010 in…
-
Alsace, Québec Consortia to Collaborate on Drug Discovery
Alsace BioValley, in Illkirch-Graffenstaden, France, a health science cluster and Québec Consortium for Drug Discovery in Nuns’ Island, Québec, Canada, signed in Paris today an agreement for a bilateral partnership to benefit Alsatian and Québec research centers and industries in the health and life sciences. The agreement calls for co-financing of R&D collaborative projects in…